Advice
In the absence of a submission from the holder of the marketing authorisation:
diclofenac 4% spray gel (Mobigel Spray ®): is not recommended for use in NHSScotland.
Indication under review: for the local symptomatic relief of mild to moderate pain and inflammation following acute blunt trauma of small and medium-sized joints and periarticular structures.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
Download detailed advice69KB (PDF)
Medicine details
- Medicine name:
- diclofenac (Mobigel Spray)
- SMC ID:
- 667/10
- Indication:
- For the local symptomatic relief of mild to moderate pain and inflammation following acute blunt trauma of small and medium-sized joints and periarticular structures
- Pharmaceutical company
- Goldshield Pharmaceuticals Limited
- BNF chapter
- Musculoskeletal and joint diseases
- Submission type
- Non submission
- Status
- Not recommended
- Date advice published
- 13 December 2010